Journal of the Practice of Cardiovascular Sciences

: 2018  |  Volume : 4  |  Issue : 3  |  Page : 159--163

Immunosuppression for postcardiac transplant patients

Dhara Singh 
 Department of Cardiology, AIIMS, New Delhi, India

Correspondence Address:
Dr. Dhara Singh
AIIMS, New Delhi

After the introduction of immunosuppressive drugs in the management of postheart transplant patients, the incidence of rejection has decreased significantly resulted in improvement in mortality and long-term outcome. Induction regimens provide intense early postoperative immune suppression while maintenance regimens are used throughout the patient's life to prevent both acute and chronic rejection. An immunosuppressive regimen tailored individually for each patient will help in decreasing the incidence of adverse events and complications. A complete understanding of currently available immunosuppressive agents is therefore essential.

How to cite this article:
Singh D. Immunosuppression for postcardiac transplant patients.J Pract Cardiovasc Sci 2018;4:159-163

How to cite this URL:
Singh D. Immunosuppression for postcardiac transplant patients. J Pract Cardiovasc Sci [serial online] 2018 [cited 2019 Jul 19 ];4:159-163
Available from:;year=2018;volume=4;issue=3;spage=159;epage=163;aulast=Singh;type=0